Organon Historical Financial Ratios
| OGN Stock | USD 15.35 0.33 2.10% |
Organon is promptly reporting on over 100 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Free Cash Flow Yield of 0.29 will help investors to properly organize and evaluate Organon financial condition quickly.
Organon |
About Organon Financial Ratios Analysis
OrganonFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Organon investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Organon financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Organon history.
Organon Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Organon stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Organon sales, a figure that is much harder to manipulate than other Organon Co multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Organon Co dividend as a percentage of Organon stock price. Organon dividend yield is a measure of Organon stock productivity, which can be interpreted as interest rate earned on an Organon investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Stock Based Compensation To Revenue
A metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards.Research And Ddevelopement To Revenue
The ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services.Most ratios from Organon's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Organon current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. At this time, Organon's Research And Ddevelopement To Revenue is very stable compared to the past year. As of the 12th of December 2024, Capex To Operating Cash Flow is likely to grow to 0.34, though PTB Ratio is likely to grow to (49.95).
| 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0409 | 0.0799 | 0.0839 | Price To Sales Ratio | 1.15 | 0.59 | 0.77 |
Organon fundamentals Correlations
Click cells to compare fundamentals
Organon Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Organon fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 1.08 | 1.04 | 1.22 | 1.15 | 0.59 | 0.77 | |
| Ptb Ratio | 1.2 | (10.28) | (5.12) | (7.96) | (52.58) | (49.95) | |
| Days Sales Outstanding | 73.22 | 49.14 | 80.02 | 87.2 | 101.64 | 60.09 | |
| Book Value Per Share | 27.79 | (3.23) | (5.95) | (3.51) | (0.27) | (0.26) | |
| Free Cash Flow Yield | 0.32 | 0.23 | 0.26 | 0.0607 | 0.15 | 0.29 | |
| Operating Cash Flow Per Share | 10.93 | 8.63 | 9.69 | 3.38 | 3.13 | 2.97 | |
| Stock Based Compensation To Revenue | 0.005272 | 0.004941 | 0.009359 | 0.0121 | 0.0161 | 0.0169 | |
| Capex To Depreciation | 0.28 | 1.77 | 2.5 | 2.01 | 1.11 | 0.89 | |
| Pb Ratio | 1.2 | (10.28) | (5.12) | (7.96) | (52.58) | (49.95) | |
| Ev To Sales | 1.05 | 0.98 | 2.56 | 2.48 | 1.88 | 1.3 | |
| Free Cash Flow Per Share | 10.57 | 7.53 | 7.77 | 1.7 | 2.11 | 2.0 | |
| Roic | 0.48 | (2.91) | 0.19 | 0.15 | 0.23 | 0.24 | |
| Inventory Turnover | 2.12 | 3.67 | 2.6 | 2.29 | 1.91 | 3.18 | |
| Net Income Per Share | 12.71 | 8.52 | 5.33 | 3.61 | 4.01 | 7.82 | |
| Days Of Inventory On Hand | 171.91 | 99.57 | 140.21 | 159.59 | 190.84 | 111.92 | |
| Payables Turnover | 8.81 | 12.92 | 1.72 | 2.03 | 1.91 | 1.82 | |
| Research And Ddevelopement To Revenue | 0.0283 | 0.0375 | 0.0703 | 0.0763 | 0.0843 | 0.0885 | |
| Capex To Revenue | 0.0118 | 0.0343 | 0.0774 | 0.0692 | 0.0417 | 0.0289 | |
| Cash Per Share | 1.26 | 1.97 | 2.91 | 2.78 | 2.72 | 1.68 | |
| Pocfratio | 3.04 | 3.85 | 3.14 | 8.27 | 4.61 | 3.16 | |
| Capex To Operating Cash Flow | 0.0332 | 0.13 | 0.2 | 0.5 | 0.33 | 0.34 | |
| Pfcf Ratio | 3.15 | 4.42 | 3.92 | 16.47 | 6.84 | 4.54 | |
| Days Payables Outstanding | 41.41 | 28.24 | 211.77 | 180.11 | 190.7 | 200.23 | |
| Income Quality | 0.84 | 1.01 | 1.82 | 0.94 | 0.78 | 1.42 | |
| Roe | 0.46 | (2.63) | (0.9) | (1.03) | (14.61) | (13.88) | |
| Ev To Operating Cash Flow | 2.96 | 3.64 | 6.56 | 17.84 | 14.7 | 15.44 | |
| Pe Ratio | 2.62 | 3.9 | 5.71 | 7.74 | 3.6 | 3.67 | |
| Return On Tangible Assets | 0.6 | 0.41 | 0.25 | 0.16 | 0.15 | 0.14 | |
| Ev To Free Cash Flow | 3.07 | 4.17 | 8.18 | 35.51 | 21.84 | 22.93 | |
| Net Debt To E B I T D A | (0.0514) | (0.16) | 4.63 | 4.86 | 5.62 | 5.9 | |
| Current Ratio | 2.95 | 2.86 | 1.45 | 1.56 | 1.54 | 2.34 | |
| Tangible Book Value Per Share | 7.36 | (23.38) | (26.67) | (24.18) | (20.4) | (21.42) | |
| Receivables Turnover | 4.99 | 7.43 | 4.56 | 4.19 | 3.59 | 5.67 | |
| Graham Number | 89.16 | 24.9 | 26.7 | 16.88 | 4.97 | 4.72 | |
| Shareholders Equity Per Share | 27.79 | (3.23) | (5.95) | (3.51) | (0.27) | (0.26) | |
| Debt To Equity | 0.0148 | (0.0378) | (6.06) | (9.99) | (125.14) | (118.89) |
Pair Trading with Organon
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will appreciate offsetting losses from the drop in the long position's value.Moving together with Organon Stock
Moving against Organon Stock
| 0.91 | BMY | Bristol Myers Squibb | PairCorr |
| 0.84 | GILD | Gilead Sciences | PairCorr |
| 0.79 | CAH | Cardinal Health | PairCorr |
| 0.73 | ESPR | Esperion Therapeutics | PairCorr |
| 0.64 | XAIR | Beyond Air | PairCorr |
The ability to find closely correlated positions to Organon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organon Co to buy it.
The correlation of Organon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organon moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Organon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.081 | Dividend Share 1.12 | Earnings Share 5.05 | Revenue Per Share 24.984 | Quarterly Revenue Growth 0.041 |
The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.